672 related articles for article (PubMed ID: 28903781)
21. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathology.
Ishiguro Y; Tsunnemi T; Shimada T; Yoroisaka A; Ueno SI; Takeshige-Amano H; Hatano T; Inoue Y; Saiki S; Hattori N
Biochem Biophys Res Commun; 2024 Apr; 703():149620. PubMed ID: 38359614
[TBL] [Abstract][Full Text] [Related]
22. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y
CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933
[TBL] [Abstract][Full Text] [Related]
23. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles.
Hong Z; Tian C; Stewart T; Aro P; Soltys D; Bercow M; Sheng L; Borden K; Khrisat T; Pan C; Zabetian CP; Peskind ER; Quinn JF; Montine TJ; Aasly J; Shi M; Zhang J
Neurology; 2021 May; 96(18):e2332-e2345. PubMed ID: 34032594
[TBL] [Abstract][Full Text] [Related]
24. Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson's Disease.
Yang Y; Stewart T; Zhang C; Wang P; Xu Z; Jin J; Huang Y; Liu Z; Lan G; Liang X; Sheng L; Shi M; Cai Z; Zhang J
Mov Disord; 2024 Jan; 39(1):40-52. PubMed ID: 37798868
[TBL] [Abstract][Full Text] [Related]
25. Increased Immune Activation by Pathologic α-Synuclein in Parkinson's Disease.
Grozdanov V; Bousset L; Hoffmeister M; Bliederhaeuser C; Meier C; Madiona K; Pieri L; Kiechle M; McLean PJ; Kassubek J; Behrends C; Ludolph AC; Weishaupt JH; Melki R; Danzer KM
Ann Neurol; 2019 Oct; 86(4):593-606. PubMed ID: 31343083
[TBL] [Abstract][Full Text] [Related]
26. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
[TBL] [Abstract][Full Text] [Related]
27. Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson's disease.
Lan G; Wang P; Chan RB; Liu Z; Yu Z; Liu X; Yang Y; Zhang J
Glia; 2022 Feb; 70(2):337-353. PubMed ID: 34713920
[TBL] [Abstract][Full Text] [Related]
28. Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice.
Huang Y; Liu Z; Li N; Tian C; Yang H; Huo Y; Li Y; Zhang J; Yu Z
Ann Neurol; 2022 Aug; 92(2):230-245. PubMed ID: 35596947
[TBL] [Abstract][Full Text] [Related]
29. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
[TBL] [Abstract][Full Text] [Related]
30. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.
Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H
J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
32. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease.
Cardinale A; Calabrese V; de Iure A; Picconi B
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204581
[TBL] [Abstract][Full Text] [Related]
33. Extracellular microvesicles-derived from microglia treated with unaggregated α-synuclein attenuate mitochondrial fission and toxicity-induced by Parkinsonian toxin MPP
Li N; Wu Y; Zhu L; Huang Y; Liu Z; Shi M; Soltys D; Zhang J; Chang Q
Biochem Biophys Res Commun; 2019 Oct; 517(4):642-647. PubMed ID: 31402119
[TBL] [Abstract][Full Text] [Related]
34. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis.
Wang P; Lan G; Xu B; Yu Z; Tian C; Lei X; Meissner WG; Feng T; Yang Y; Zhang J
Transl Neurodegener; 2023 Aug; 12(1):40. PubMed ID: 37620916
[TBL] [Abstract][Full Text] [Related]
35. Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease.
Kim D; Yoo JM; Hwang H; Lee J; Lee SH; Yun SP; Park MJ; Lee M; Choi S; Kwon SH; Lee S; Kwon SH; Kim S; Park YJ; Kinoshita M; Lee YH; Shin S; Paik SR; Lee SJ; Lee S; Hong BH; Ko HS
Nat Nanotechnol; 2018 Sep; 13(9):812-818. PubMed ID: 29988049
[TBL] [Abstract][Full Text] [Related]
36. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.
Reynolds AD; Glanzer JG; Kadiu I; Ricardo-Dukelow M; Chaudhuri A; Ciborowski P; Cerny R; Gelman B; Thomas MP; Mosley RL; Gendelman HE
J Neurochem; 2008 Mar; 104(6):1504-25. PubMed ID: 18036154
[TBL] [Abstract][Full Text] [Related]
37. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.
Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM
Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897
[TBL] [Abstract][Full Text] [Related]
38. microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.
Thome AD; Harms AS; Volpicelli-Daley LA; Standaert DG
J Neurosci; 2016 Feb; 36(8):2383-90. PubMed ID: 26911687
[TBL] [Abstract][Full Text] [Related]
39. Inflammation leads to distinct populations of extracellular vesicles from microglia.
Yang Y; Boza-Serrano A; Dunning CJR; Clausen BH; Lambertsen KL; Deierborg T
J Neuroinflammation; 2018 May; 15(1):168. PubMed ID: 29807527
[TBL] [Abstract][Full Text] [Related]
40. Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.
Agliardi C; Meloni M; Guerini FR; Zanzottera M; Bolognesi E; Baglio F; Clerici M
Neurobiol Dis; 2021 Jan; 148():105185. PubMed ID: 33217562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
